Skip to main content
Clinical Trials/DRKS00025907
DRKS00025907
Not yet recruiting
Phase 1

Development and neurobiological investigation of a social-cognitive intervention for patients with schizophrenia

niversitätsklinikum Gießen und Marburg, Standort Marburg0 sites50 target enrollmentAugust 12, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
F20-F29
Sponsor
niversitätsklinikum Gießen und Marburg, Standort Marburg
Enrollment
50
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 12, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Gießen und Marburg, Standort Marburg

Eligibility Criteria

Inclusion Criteria

  • 1\) Signed informed consent
  • 2\) For all patients, a diagnosis in the schizophrenia spectrum according to ICD\-10 criteria (F20\.\-29\.)

Exclusion Criteria

  • 1\) Neurological pre\-existing conditions
  • 2\) MRI incompatibility (detected by MRI screening)
  • 3\) Lack of ability to consent to study participation

Outcomes

Primary Outcomes

Not specified

Similar Trials